A recent meta‐analysis on tumor‐infiltrating immune cells suggested that the amount and density of tumor‐infiltrating CD8+ T cell also affected survival in HNSCC patients,30 whereas there is controversy as to whether higher levels of tumor‐infiltrating CD8+ T cells improve survival in patients with OSCC. The gene discussed is CD8A; the disease is neoplasm.